Healthcare -
Biotechnology - NASDAQ - US
$ 1.98
-1.01 %
$ 147 M
Market Cap
-3.38
P/E
IKT - COST OF REVENUE
Cost of Revenue IKT - Inhibikase Therapeutics, Inc.
0
LAST VALUE
0.00%
2 YEAR CAGR
0.00%
5 YEAR CAGR
0.00%
10 YEAR CAGR